FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313466074> ?p ?o ?g. }

• W4313466074 abstract "Background A low estimated glomerular filtration rate (eGFR &lt;90 mL/min/1.73 m 2 ) is widely recognized as a risk factor for major adverse cardiac events (MACE) after percutaneous coronary intervention (PCI) for chronic total occlusion (CTO). However, the impact of successful CTO-PCI on quality of life (QOL) of patients with low eGFR remains unknown. Objectives The aim of this prospective study was to assess the QOL of CTO patients with low eGFR after successful PCI. Methods Consecutive patients undergoing elective CTO-PCI were prospectively enrolled and subdivided into four groups: eGFR ≥90 mL/min/1.73 m 2 ( n = 410), 90 &gt; eGFR ≥ 60 mL/min/1.73 m 2 ( n = 482), 60 &gt; eGFR ≥ 30 mL/min/1.73 m 2 ( n = 161), and eGFR &lt;30 mL/min/1.73 m 2 ( n = 23). The primary outcomes included QOL, as assessed with the European Quality of Life-5 Dimensions (EQ-5D) questionnaire, and symptoms, as assessed with the Rose Dyspnea Scale (RDS) and Seattle Angina Questionnaire (SAQ), at 1 month and 1 year after successful PCI. Results With the decline of eGFR, CTO patients were more likely to present with comorbidities of hypertension, diabetes, hyperuricemia, and previous stroke, in addition to lower hemoglobin levels and left ventricular ejection fraction ( p &lt; 0.05). Low eGFR was associated with greater incidences of in-hospital pericardiocentesis, major bleeding, acute renal failure, and subcutaneous hematoma, but not in-hospital MACE ( p &lt; 0.05). Symptoms of dyspnea and angina were alleviated in all CTO patients with eGFR ≥30 mL/min/1.73 m 2 at 1 month and 1 year after successful CTO-PCI, but only at 1 month for those with eGFR &lt;30 mL/min/1.73 m 2 ( p &lt; 0.01). Importantly, QOL was markedly improved at 1 month and 1 year after successful PCI ( p &lt; 0.01), notably at a similar degree between patients with low eGFR and those with normal eGFR ( p &gt; 0.05). Conclusion Successful PCI effectively improved symptoms and QOL of CTO patients with low eGFR." @default.
• W4313466074 created "2023-01-06" @default.
• W4313466074 creator A5005050685 @default.
• W4313466074 creator A5006566087 @default.
• W4313466074 creator A5009988205 @default.
• W4313466074 creator A5015771947 @default.
• W4313466074 creator A5016641955 @default.
• W4313466074 creator A5017141333 @default.
• W4313466074 creator A5019869078 @default.
• W4313466074 creator A5021502269 @default.
• W4313466074 creator A5029145191 @default.
• W4313466074 creator A5029256927 @default.
• W4313466074 creator A5033265749 @default.
• W4313466074 creator A5037458498 @default.
• W4313466074 creator A5046597133 @default.
• W4313466074 creator A5046687607 @default.
• W4313466074 creator A5051388546 @default.
• W4313466074 creator A5074016661 @default.
• W4313466074 creator A5077902385 @default.
• W4313466074 creator A5082114171 @default.
• W4313466074 date "2022-12-21" @default.
• W4313466074 modified "2023-09-29" @default.
• W4313466074 title "Percutaneous coronary intervention improves quality of life of patients with chronic total occlusion and low estimated glomerular filtration rate" @default.
• W4313466074 cites W2024754526 @default.
• W4313466074 cites W2049373789 @default.
• W4313466074 cites W2073742622 @default.
• W4313466074 cites W2082069148 @default.
• W4313466074 cites W2089737914 @default.
• W4313466074 cites W2109647832 @default.
• W4313466074 cites W2120309176 @default.
• W4313466074 cites W2144625297 @default.
• W4313466074 cites W2153141951 @default.
• W4313466074 cites W2153836018 @default.
• W4313466074 cites W2155046805 @default.
• W4313466074 cites W2182015005 @default.
• W4313466074 cites W2186753351 @default.
• W4313466074 cites W2319874299 @default.
• W4313466074 cites W2475261460 @default.
• W4313466074 cites W2476275020 @default.
• W4313466074 cites W2515440205 @default.
• W4313466074 cites W2743515617 @default.
• W4313466074 cites W2759078218 @default.
• W4313466074 cites W2767083950 @default.
• W4313466074 cites W2767316536 @default.
• W4313466074 cites W2768615381 @default.
• W4313466074 cites W2789371315 @default.
• W4313466074 cites W2801132219 @default.
• W4313466074 cites W2885019126 @default.
• W4313466074 cites W2916496138 @default.
• W4313466074 cites W2933619227 @default.
• W4313466074 cites W2935857572 @default.
• W4313466074 cites W2965902961 @default.
• W4313466074 cites W2969668000 @default.
• W4313466074 cites W2994612068 @default.
• W4313466074 cites W2999368437 @default.
• W4313466074 cites W3023790987 @default.
• W4313466074 cites W3026360856 @default.
• W4313466074 cites W3035334223 @default.
• W4313466074 cites W3100516404 @default.
• W4313466074 cites W3121699021 @default.
• W4313466074 cites W3126800207 @default.
• W4313466074 cites W3133359436 @default.
• W4313466074 cites W3138323549 @default.
• W4313466074 cites W3160763179 @default.
• W4313466074 cites W3163845177 @default.
• W4313466074 cites W3186486251 @default.
• W4313466074 cites W3194933011 @default.
• W4313466074 cites W3215851199 @default.
• W4313466074 cites W4223425657 @default.
• W4313466074 doi "https://doi.org/10.3389/fcvm.2022.1019688" @default.
• W4313466074 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36620621" @default.
• W4313466074 hasPublicationYear "2022" @default.
• W4313466074 type Work @default.
• W4313466074 citedByCount "0" @default.
• W4313466074 crossrefType "journal-article" @default.
• W4313466074 hasAuthorship W4313466074A5005050685 @default.
• W4313466074 hasAuthorship W4313466074A5006566087 @default.
• W4313466074 hasAuthorship W4313466074A5009988205 @default.
• W4313466074 hasAuthorship W4313466074A5015771947 @default.
• W4313466074 hasAuthorship W4313466074A5016641955 @default.
• W4313466074 hasAuthorship W4313466074A5017141333 @default.
• W4313466074 hasAuthorship W4313466074A5019869078 @default.
• W4313466074 hasAuthorship W4313466074A5021502269 @default.
• W4313466074 hasAuthorship W4313466074A5029145191 @default.
• W4313466074 hasAuthorship W4313466074A5029256927 @default.
• W4313466074 hasAuthorship W4313466074A5033265749 @default.
• W4313466074 hasAuthorship W4313466074A5037458498 @default.
• W4313466074 hasAuthorship W4313466074A5046597133 @default.
• W4313466074 hasAuthorship W4313466074A5046687607 @default.
• W4313466074 hasAuthorship W4313466074A5051388546 @default.
• W4313466074 hasAuthorship W4313466074A5074016661 @default.
• W4313466074 hasAuthorship W4313466074A5077902385 @default.
• W4313466074 hasAuthorship W4313466074A5082114171 @default.
• W4313466074 hasBestOaLocation W43134660741 @default.
• W4313466074 hasConcept C126322002 @default.
• W4313466074 hasConcept C134018914 @default.
• W4313466074 hasConcept C159110408 @default.
• W4313466074 hasConcept C159641895 @default.
• W4313466074 hasConcept C164705383 @default.
• W4313466074 hasConcept C2778425758 @default.

• next